These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4731481)

  • 21. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatoxic side-effects of rifampicin. A comparative clinical study].
    Kuntz HD; Rausch V
    Med Welt; 1977 Nov; 28(47):1940-2. PubMed ID: 342868
    [No Abstract]   [Full Text] [Related]  

  • 23. Jaundice associated with rifampicin.
    Hollins PJ; Simmons AV
    Tubercle; 1970 Sep; 51(3):328-32. PubMed ID: 5495656
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fatal liver cell necrosis following short-term administration of isoniazid and rifampicin to a patient already under treatment with antiepileptics].
    Lenders JW; Bartelink AK; van Herwaarden CL; van Haelst UJ; van Tongeren JH
    Ned Tijdschr Geneeskd; 1983 Mar; 127(10):420-3. PubMed ID: 6835412
    [No Abstract]   [Full Text] [Related]  

  • 25. [The results of liver biopsies during rifampicin therapy (author's transl)].
    Kozma D; Lapis K; Tompa A
    Prax Pneumol; 1976 Dec; 30(12):764-70. PubMed ID: 1013060
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic toxicity of antituberculous drugs in children.
    Allué X; Sanjurjo P; Fidalgo I; Bilbao F
    Helv Paediatr Acta; 1976 Dec; 31(4-5):381-7. PubMed ID: 1017983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 29. [Jaundice during rifampicin treatment].
    Ollagnier C; Vallon C
    J Med Lyon; 1971 May; 52(120):835-6 passim. PubMed ID: 5136252
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse reactions during rifampicin treatment.
    Riska N; Mattson K
    Scand J Respir Dis; 1972; 53(2):87-96. PubMed ID: 5052728
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of rifampicin in tuberculous patients with liver diseases].
    Pozzi E; Menghini P
    G Ital Chemioter; 1972 Jul; 19(3):63-8. PubMed ID: 4671348
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].
    Abeledo Mezquita G; Otero Reigada MC
    An Esp Pediatr; 1977 Feb; 10(2):167-70. PubMed ID: 869341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
    Burke M; Logan J
    Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin].
    Waitzberg VR; Gayotto LC
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Feb; 37(1):48-51. PubMed ID: 7123064
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-tuberculosis chemotherapy and management of adverse reactions].
    Kuwabara K
    Nihon Rinsho; 2011 Aug; 69(8):1389-93. PubMed ID: 21838035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenytoin toxicity due to rifampicin induced hepatic dysfunction.
    Chandra RS; Dalvi SS; Powar HS; Karnad PD; Kshirsagar NA
    J Assoc Physicians India; 1993 Aug; 41(8):536-7. PubMed ID: 8294367
    [No Abstract]   [Full Text] [Related]  

  • 39. [Liver toxicity of rifampicin].
    Austerhoff A; Knop P; Brennecke FG; Kindler U; Scholten T; Knieriem HJ
    Med Welt; 1973 Apr; 24(17):695-6. PubMed ID: 4750930
    [No Abstract]   [Full Text] [Related]  

  • 40. [Increase in transaminases and jaundice during treatment with rifampicin combined with isoniazid].
    Kreis B; Boutonnet G
    Rev Tuberc Pneumol (Paris); 1970 Dec; 34(8):1097-106. PubMed ID: 5517156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.